MRI guided iron assessment and oral chelator use improve iron status in thalassemia major patients

American Journal of Hematology

Volumn 89, Issue 7, 2014, Pages 684-688

  Nichols Vinueza, Diana X ^a   White, Matthew T ^a   Powell, Andrew J ^a   Banka, Puja ^a   Neufeld, Ellis J ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON; IRON CHELATING AGENT;

ADOLESCENT; ADULT; ALPHA THALASSEMIA; ARTICLE; BETA THALASSEMIA; CLINICAL ARTICLE; DRY WEIGHT; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HEART FAILURE; HUMAN; IRON CHELATION; IRON OVERLOAD; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; BETA-THALASSEMIA; CHILD; FEMALE; HUMANS; IRON; IRON CHELATING AGENTS; IRON OVERLOAD; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MEDICATION ADHERENCE; MYOCARDIUM; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84902806913     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23715     Document Type: Article

References (20)

1. Rachmilewitz EA, Giardina PJ. How I treat thalassemia. Blood 2011;118:3479-3488.
2. Chu WC, Au WY, Lam WW. MRI of cardiac iron overload. J Magn Reson Imaging 2012;36:1052-1059.
3. Uygun V, Kurtoglu E. Iron-chelation therapy with oral chelators in patients with thalassemia major. Hematology 2013;18:50-55.
4. Kondur AK, Li T, Vaitkevicius P, Afonso L. Quantification of myocardial iron overload by cardiovascular magnetic resonance imaging T2* and review of the literature. Clin Cardiol 2009;32:E55-E59.
5. Feng Y, He T, Carpenter JP, et al. In vivo comparison of myocardial T1 with T2 and T2* in thalassaemia major. J Magn Reson Imaging 2013;38:588-593.
6. Kwiatkowski JL, Kim HY, Thompson AA, et al. Chelation use and iron burden in North American and British thalassemia patients: A report from the Thalassemia Longitudinal Cohort. Blood 2012;119:2746-2753.
7. Huber H, Lienert GA. [A Wilcoxon signed rank test for stratified samples]. Methods Inf Med 1972;11:121-124.
8. St Pierre TG, Clark PR, Chua-anusorn W, et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005;105:855-861.
9. Wood JC, Enriquez C, Ghugre N, et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005;106:1460-1465.
10. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-2179.
11. Ambati SR, Randolph RE, Mennitt K, et al. Longitudinal monitoring of cardiac siderosis using cardiovascular magnetic resonance T2* in patients with thalassemia major on various chelation regimens: A 6-year study. Am J Hematol 2013;88:652-656.
12. Modell B, Khan M, Darlison M, et al. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2008;10:42.
13. Kirk P, Roughton M, Porter JB, et al. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation 2009;120:1961-1968.
14. Tanner MA, Galanello R, Dessi C, et al. Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. J Cardiovasc Magn Reson 2006;8:543-547.
15. Deborah Chirnomas S, Geukes-Foppen M, Barry K, et al. Practical implications of liver and heart iron load assessment by T2*-MRI in children and adults with transfusion-dependent anemias. Am J Hematol 2008;83:781-783.
16. Noetzli LJ, Carson SM, Nord AS, et al. Longitudinal analysis of heart and liver iron in thalassemia major. Blood 2008;112:2973-2978.
17. Wood JC. Diagnosis and management of transfusion iron overload: The role of imaging. Am J Hematol 2007;82:1132-1135.
18. Wood JC, Mo A, Gera A, et al. Quantitative computed tomography assessment of transfusional iron overload. Br J Haematol 2011;153:780-785.
19. Chirnomas D, Smith AL, Braunstein J, et al. Deferasirox pharmacokinetics in patients with adequate versus inadequate response. Blood 2009;114:4009-4013.
20. Queiroz-Andrade M, Blasbalg R, Ortega CD, et al. MR imaging findings of iron overload. Radiographics 2009;29:1575-1589.